Diabetology & Metabolic Syndrome
Scope & Guideline
Unlocking insights for a healthier tomorrow.
Introduction
Aims and Scopes
- Diabetes Management and Treatment Strategies:
Research on various treatment modalities for diabetes, including pharmacological interventions (like GLP-1 receptor agonists and SGLT2 inhibitors), dietary approaches, and lifestyle modifications aimed at improving glycemic control and managing diabetes-related complications. - Cardiometabolic Health:
Studies investigating the interrelations between diabetes and cardiovascular diseases, metabolic syndrome, and other comorbidities, focusing on risk factors, outcomes, and management strategies. - Pathophysiology of Diabetes Complications:
Research into the underlying mechanisms of diabetes-related complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease, often utilizing molecular, genetic, and epigenetic analyses. - Innovative Diagnostic and Monitoring Technologies:
Advancements in diabetes monitoring technologies such as continuous glucose monitoring systems, machine learning applications for diabetes risk prediction, and novel biomarkers for early detection of diabetes-related complications. - Public Health and Epidemiology:
Investigations into the prevalence, risk factors, and socio-economic impacts of diabetes and metabolic syndrome at population levels, aiming to inform public health policies and interventions. - Patient-Centered Care and Education:
Research focusing on the psychosocial aspects of diabetes, including patient education, self-management strategies, and the impact of mental health on diabetes outcomes.
Trending and Emerging
- Molecular Mechanisms and Biomarkers:
There is a growing emphasis on understanding the molecular mechanisms underlying diabetes and its complications, including the identification of novel biomarkers for early detection and monitoring of diabetes-related conditions. - Impact of Gut Microbiota:
Research exploring the relationship between gut microbiota and diabetes has gained traction, focusing on how gut health influences metabolic processes, insulin resistance, and overall diabetes management. - Psychosocial and Behavioral Aspects of Diabetes Management:
Increasing attention is being paid to the psychosocial dimensions of diabetes, including the effects of mental health, stress, and social support on diabetes outcomes, as well as the role of patient education and self-management. - Artificial Intelligence and Digital Health Technologies:
The integration of artificial intelligence and digital health technologies in diabetes management is an emerging trend, with studies focusing on predictive modeling, telemedicine, and mobile health applications to enhance patient care. - Diabetes in Special Populations:
Research focusing on diabetes management and outcomes in specific populations, such as children, adolescents, pregnant women, and ethnic minorities, is gaining importance, reflecting the need for tailored approaches in diabetes care.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for diabetes management, such as specific diets or food groups, has seen a decline. This shift is likely due to a growing emphasis on personalized nutrition and the role of overall dietary patterns. - Single-Agent Pharmacotherapy Studies:
The focus on studies investigating single-agent pharmacotherapy for diabetes management has waned. There is now a greater interest in combination therapies and multi-faceted approaches that address the complexity of diabetes. - Basic Science Studies with Limited Clinical Relevance:
While basic science research remains important, studies that do not translate findings into clinical or practical applications are less prevalent. The journal is increasingly prioritizing research that has direct implications for patient care and outcomes. - Generalized Population Studies:
Research that broadly examines diabetes prevalence without nuanced analysis of specific populations or subgroups is decreasing. There is a trend towards more targeted studies that consider ethnic, cultural, and socio-economic factors influencing diabetes.
Similar Journals
DIABETES-METABOLISM RESEARCH AND REVIEWS
Uniting Experts to Tackle Diabetes ChallengesDIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.
Diabetes Stoffwechsel und Herz
Pioneering Discussions on Diabetes and Cardiovascular RelationshipsDiabetes Stoffwechsel und Herz, published by VERLAG KIRCHHEIM, is a distinguished journal that focuses on the interdisciplinary field of diabetes research, cardiology, and metabolic disorders. With its dedicated approach, the journal aims to disseminate cutting-edge findings and foster innovative discussions among researchers and practitioners in the healthcare community. Despite its discontinuation in Scopus coverage since 2017, the journal continues to hold significance in advancing knowledge regarding the intricate relationship between diabetes and cardiovascular health. It offers researchers a platform to explore the biochemical, genetic, and clinical aspects of endocrinology, while also catering to the needs of professionals aiming to apply the latest research in their practice. The journal’s rankings, which place it in the lower percentiles across various relevant categories, reflect a unique opportunity for contributors looking to impact a niche yet vital area of medicine. As the field evolves, Diabetes Stoffwechsel und Herz remains committed to enriching the dialogue surrounding these critical health issues.
DIABETES OBESITY & METABOLISM
Bridging science and clinical practice in metabolic health.DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.
Metabolic Syndrome and Related Disorders
Transforming Knowledge into Better Health OutcomesMetabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.
BMC Endocrine Disorders
Championing open access to vital endocrine research.BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.
Diabetology
Advancing knowledge in diabetes and metabolism.Diabetology, published by MDPI, is an esteemed Open Access journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. Launched in 2020, this journal has quickly established itself, achieving a Category Quartile ranking of Q3 in Endocrinology, Diabetes and Metabolism and Q2 in Internal Medicine as of 2023. With a commitment to disseminating high-quality research, Diabetology provides an important platform for scientists, healthcare professionals, and students to contribute to the growing body of knowledge regarding diabetes and related conditions. Operating from its headquarters in Basel, Switzerland, the journal embraces an open access model, ensuring that research is accessible worldwide, fostering collaboration and innovation in this critical area of health. As the global diabetic epidemic continues to evolve, Diabetology plays a vital role in informing and educating stakeholders through rigorous peer-reviewed articles while boosting its visibility with impressive Scopus rankings. This journal is not only a resource for current data and findings but also a hub for groundbreaking studies that strive to improve patient outcomes and inform public health policies.
DIABETES CARE
Transforming knowledge into diabetes care solutions.DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Elevating Clinical Standards Through Rigorous ResearchJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.
Endocrinology Diabetes and Metabolism Case Reports
Advancing Knowledge in Endocrinology and MetabolismEndocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.
Journal of the ASEAN Federation of Endocrine Societies
Advancing Endocrinology: Bridging Knowledge Across ASEANWelcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.